Clinical pharmacology of the new betaadrenergic blocking drugs. Part 13. The betaadrenoceptor blocking drugs: A perspective
- 1 May 1980
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 99 (5) , 665-670
- https://doi.org/10.1016/0002-8703(80)90741-3
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina PectorisNew England Journal of Medicine, 1979
- Suppression of Hypoglycemia by DL-Propranolol in Malignant InsulinomaNew England Journal of Medicine, 1978
- Propranolol withdrawal syndrome - why?Circulation, 1978
- A functional basis for classification of α-adrenergic receptorsLife Sciences, 1977
- Elevated beta-adrenergic receptor number after chronic propranolol treatmentBiochemical and Biophysical Research Communications, 1977
- Propranolol for patients with mitral valve prolapseAmerican Heart Journal, 1977
- Clinical Pharmacokinetics of β-Adrenoreceptor Blocking DrugsClinical Pharmacokinetics, 1976
- Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral PropranololCirculation, 1974
- Beta adrenergic blockade and juvenile diabetes: Acute studies and long-term therapeutic trial: Evidence for the role of catecholamines in mediating diabetic decompensation following emotional arousalThe Journal of Pediatrics, 1969
- Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic BlockadeCirculation, 1967